Tapewire

Nasdaq · USD

ZVRA

ZEVRA THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
5212
SEC CIK
0001434647
Parsed reports
261

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202604
Feb 202604
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 202602
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 25, 2023 Filed May 9, 2023 01:53 UTC GrantStock Option (right to buy) · Derivative 49,200 $0.00 Strike: $5.59 $0.00
Disclosure

SEC source: 0001437749-23-013125 · rdgdoc.xml · derivative · entry 1

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,200

Underlying: Common Stock · 49,200 shares

Expires 2033-04-24

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, April 25, 2023.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's eighth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
April 25, 2023 Filed May 9, 2023 01:51 UTC GrantStock Option (right to buy) · Derivative 39,200 $0.00 Strike: $5.59 $0.00
Disclosure

SEC source: 0001437749-23-013124 · rdgdoc.xml · derivative · entry 1

FAVORITO TAMARA A · CIK 0001288232 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,200

Underlying: Common Stock · 39,200 shares

Expires 2033-04-24

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, April 25, 2023.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's eighth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
April 25, 2023 Filed May 9, 2023 01:50 UTC GrantStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $5.59 $0.00
Disclosure

SEC source: 0001437749-23-013123 · rdgdoc.xml · derivative · entry 1

DIXON WENDY L · CIK 0001202283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2033-04-24

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, April 25, 2023.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors.

F3 · derivative.exercise_date: 33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer.

Read SEC document
March 17, 2023 Filed Mar 21, 2023 20:32 UTC PurchaseCommon Stock 519 $4.82 $2,502.36
Disclosure

SEC source: 0001437749-23-007397 · rdgdoc.xml · nonDerivative · entry 1

SEYMOUR TAMARA A · CIK 0001288232 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 719

Read SEC document
March 14, 2023 Filed Mar 16, 2023 00:14 UTC
Schafer JoshuaCCO & EVP, Bus. Development
PurchaseCommon Stock 2,000 $4.61 $9,217.80
Disclosure

SEC source: 0001437749-23-006771 · rdgdoc.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
March 10, 2023 Filed Mar 13, 2023 07:56 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
PurchaseCommon Stock 1,725 $4.15 $7,158.75
Disclosure

SEC source: 0001437749-23-006277 · rdgdoc.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,002

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:57 UTC
Sangiovanni Timothy J.SVP, Corporate Controller
PurchaseCommon Stock 100 $4.14 $413.50
Disclosure

SEC source: 0001437749-23-006278 · rdgdoc.xml · nonDerivative · entry 2

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,449

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:57 UTC
Sangiovanni Timothy J.SVP, Corporate Controller
PurchaseCommon Stock 1,100 $4.14 $4,553.67
Disclosure

SEC source: 0001437749-23-006278 · rdgdoc.xml · nonDerivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,349

Read SEC document
March 09, 2023 Filed Mar 13, 2023 11:59 UTC PurchaseCommon Stock 11,000 $4.20 $46,148.30
Disclosure

SEC source: 0001437749-23-006280 · rdgdoc.xml · nonDerivative · entry 1

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1166 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · ownership.direct: Held jointly with spouse.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 11:54 UTC PurchaseCommon Stock 5,000 $4.15 $20,731.50
Disclosure

SEC source: 0001437749-23-006276 · rdgdoc.xml · nonDerivative · entry 1

Tierney David S · CIK 0001292636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,835

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 11:53 UTC
Pascoe Richard WDirector · Chief Executive Officer
PurchaseCommon Stock 10,000 $4.20 $41,978.00
Disclosure

SEC source: 0001437749-23-006274 · rdgdoc.xml · nonDerivative · entry 1

Pascoe Richard W · CIK 0001343266 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,973

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.16 to $4.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 13, 2023 Filed Jan 13, 2023 17:28 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
PurchaseCommon Stock 25 $5.59 $139.63
Disclosure

SEC source: 0001437749-23-001060 · rdgdoc.xml · nonDerivative · entry 2

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,277

Read SEC document
January 13, 2023 Filed Jan 13, 2023 17:28 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
PurchaseCommon Stock 610 $5.82 $3,550.20
Disclosure

SEC source: 0001437749-23-001060 · rdgdoc.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,252

Read SEC document
January 13, 2023 Filed Jan 13, 2023 22:27 UTC
Pascoe Richard WDirector · Chief Executive Officer
PurchaseCommon Stock 9,500 $5.44 $51,679.05
Disclosure

SEC source: 0001437749-23-001059 · rdgdoc.xml · nonDerivative · entry 1

Pascoe Richard W · CIK 0001343266 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,973

Read SEC document
January 09, 2023 Filed Jan 11, 2023 21:57 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
GrantStock Option (right to buy) · Derivative 459,726 $0.00 Strike: $4.54 $0.00
Disclosure

SEC source: 0001437749-23-000919 · rdgdoc.xml · derivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 459,726

Underlying: Common Stock · 459,726 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 09, 2023 Filed Jan 12, 2023 02:52 UTC
Mickle Christal M MChief Product Dev. Officer
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $4.54 $0.00
Disclosure

SEC source: 0001437749-23-000917 · rdgdoc.xml · derivative · entry 1

Mickle Christal M M · CIK 0001638366 · Chief Product Dev. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 09, 2023 Filed Jan 12, 2023 02:50 UTC
Guenther SvenChief Scientific Officer
GrantStock Option (right to buy) · Derivative 306,000 $0.00 Strike: $4.54 $0.00
Disclosure

SEC source: 0001437749-23-000916 · rdgdoc.xml · derivative · entry 1

Guenther Sven · CIK 0001638368 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,000

Underlying: Common Stock · 306,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 09, 2023 Filed Jan 12, 2023 02:49 UTC
Schafer JoshuaCCO & EVP, Bus. Development
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $4.54 $0.00
Disclosure

SEC source: 0001437749-23-000915 · rdgdoc.xml · derivative · entry 1

Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 09, 2023 Filed Jan 12, 2023 02:46 UTC
Pascoe Richard WDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 700,000 $0.00 Strike: $4.54 $0.00
Disclosure

SEC source: 0001437749-23-000914 · rdgdoc.xml · derivative · entry 1

Pascoe Richard W · CIK 0001343266 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700,000

Underlying: Common Stock · 700,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 09, 2023 Filed Jan 12, 2023 02:45 UTC
Sangiovanni Timothy J.SVP, Corporate Controller
GrantStock Option (right to buy) · Derivative 136,986 $0.00 Strike: $4.54 $0.00
Disclosure

SEC source: 0001437749-23-000913 · rdgdoc.xml · derivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,986

Underlying: Common Stock · 136,986 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 19:57 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
PurchaseCommon Stock 400 $5.98 $2,393.20
Disclosure

SEC source: 0001437749-22-023512 · rdgdoc.xml · nonDerivative · entry 2

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,109

Read SEC document
September 30, 2022 Filed Oct 3, 2022 19:57 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
PurchaseCommon Stock 600 $5.98 $3,588.00
Disclosure

SEC source: 0001437749-22-023512 · rdgdoc.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,709

Read SEC document
June 28, 2022 Filed Jun 30, 2022 21:20 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001437749-22-016303 · rdgdoc.xml · derivative · entry 1

Tierney David S · CIK 0001292636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-27

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 28, 2022 Filed Jun 30, 2022 21:20 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001437749-22-016302 · rdgdoc.xml · derivative · entry 1

Saluri Joseph · CIK 0001512131 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-27

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 28, 2022 Filed Jun 30, 2022 21:19 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001437749-22-016301 · rdgdoc.xml · derivative · entry 1

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-27

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 28, 2022 Filed Jun 30, 2022 21:19 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001437749-22-016300 · rdgdoc.xml · derivative · entry 1

SEYMOUR TAMARA A · CIK 0001288232 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-27

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 25, 2022 Filed May 26, 2022 01:03 UTC
Mickle Travis CDirector · President & CEO
PurchaseCommon Stock 10,000 $4.39 $43,900.00
Disclosure

SEC source: 0001437749-22-013570 · rdgdoc.xml · nonDerivative · entry 3

Mickle Travis C · CIK 0001638365 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Mickle Investments LLC

Disclosed balance after: 11,034

F1 · ownership.nature: The Reporting Person is the sole manager member of Mickle Investments, LLC.

Read SEC document
May 25, 2022 Filed May 26, 2022 01:03 UTC
Mickle Travis CDirector · President & CEO
PurchaseCommon Stock 1,000 $4.39 $4,385.00
Disclosure

SEC source: 0001437749-22-013570 · rdgdoc.xml · nonDerivative · entry 2

Mickle Travis C · CIK 0001638365 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,521

Read SEC document
May 25, 2022 Filed May 26, 2022 01:03 UTC
Mickle Travis CDirector · President & CEO
PurchaseCommon Stock 2,000 $4.36 $8,711.00
Disclosure

SEC source: 0001437749-22-013570 · rdgdoc.xml · nonDerivative · entry 1

Mickle Travis C · CIK 0001638365 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,521

Read SEC document
May 25, 2022 Filed May 27, 2022 00:30 UTC PurchaseCommon Stock 2,000 $4.39 $8,780.00
Disclosure

SEC source: 0001437749-22-013706 · rdgdoc.xml · nonDerivative · entry 1

Tierney David S · CIK 0001292636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,835

Read SEC document
May 20, 2022 Filed May 25, 2022 00:58 UTC PurchaseCommon Stock 200 $4.87 $974.00
Disclosure

SEC source: 0001437749-22-013468 · rdgdoc.xml · nonDerivative · entry 1

SEYMOUR TAMARA A · CIK 0001288232 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

Read SEC document
May 18, 2022 Filed May 18, 2022 17:17 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
PurchaseCommon Stock 1,200 $5.00 $5,999.04
Disclosure

SEC source: 0001437749-22-012932 · rdgdoc.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,440

Read SEC document
May 18, 2022 Filed May 18, 2022 23:01 UTC PurchaseCommon Stock 339 $4.97 $1,684.83
Disclosure

SEC source: 0001437749-22-012945 · rdgdoc.xml · nonDerivative · entry 4

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

F1 · ownership.direct: Held jointly with spouse.

Read SEC document
May 18, 2022 Filed May 18, 2022 23:01 UTC PurchaseCommon Stock 3,051 $4.96 $15,132.96
Disclosure

SEC source: 0001437749-22-012945 · rdgdoc.xml · nonDerivative · entry 3

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,161

F1 · ownership.direct: Held jointly with spouse.

Read SEC document
May 18, 2022 Filed May 18, 2022 23:01 UTC PurchaseCommon Stock 915 $4.95 $4,529.25
Disclosure

SEC source: 0001437749-22-012945 · rdgdoc.xml · nonDerivative · entry 2

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,110

F1 · ownership.direct: Held jointly with spouse.

Read SEC document
May 18, 2022 Filed May 18, 2022 23:01 UTC PurchaseCommon Stock 695 $4.94 $3,433.30
Disclosure

SEC source: 0001437749-22-012945 · rdgdoc.xml · nonDerivative · entry 1

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,195

F1 · ownership.direct: Held jointly with spouse.

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 333 $4.94 $1,645.02
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 7

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,285

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 1,700 $4.93 $8,381.00
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 6

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,952

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 1,767 $4.92 $8,693.64
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 5

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,252

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 400 $4.91 $1,964.00
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 4

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,485

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 400 $4.91 $1,963.96
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 3

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,085

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 100 $4.90 $490.00
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 2

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,685

Read SEC document
May 18, 2022 Filed May 18, 2022 21:25 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 300 $4.90 $1,469.97
Disclosure

SEC source: 0001437749-22-012933 · rdgdoc.xml · nonDerivative · entry 1

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,585

Read SEC document
February 01, 2022 Filed Feb 3, 2022 17:15 UTC
Clifton R. LaDuaneCFO, Secretary & Treasurer
GrantStock Option (right to buy) · Derivative 83,486 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001437749-22-002399 · rdgdoc.xml · derivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO, Secretary & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,486

Underlying: Common Stock · 83,486 shares

Expires 2032-01-31

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:17 UTC
Sangiovanni Timothy J.VP, Corporate Controller
GrantStock Option (right to buy) · Derivative 50,092 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001437749-22-002401 · rdgdoc.xml · derivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,092

Underlying: Common Stock · 50,092 shares

Expires 2032-01-31

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:17 UTC
Guenther SvenEVP, Research & Development
GrantStock Option (right to buy) · Derivative 83,486 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001437749-22-002400 · rdgdoc.xml · derivative · entry 1

Guenther Sven · CIK 0001638368 · EVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,486

Underlying: Common Stock · 83,486 shares

Expires 2032-01-31

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:14 UTC
Pascoe Richard WDirector · Executive Chairman
GrantStock Option (right to buy) · Derivative 127,286 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001437749-22-002398 · rdgdoc.xml · derivative · entry 1

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,286

Underlying: Common Stock · 127,286 shares

Expires 2032-01-31

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:12 UTC
Mickle Travis CDirector · President & CEO
GrantStock Option (right to buy) · Derivative 267,156 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001437749-22-002397 · rdgdoc.xml · derivative · entry 1

Mickle Travis C · CIK 0001638365 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,156

Underlying: Common Stock · 267,156 shares

Expires 2032-01-31

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
December 01, 2021 Filed Dec 1, 2021 21:28 UTC GrantCommon Stock 2,500 $8.44 $21,100.00
Disclosure

SEC source: 0001437749-21-027630 · rdgdoc.xml · nonDerivative · entry 1

Plooster Matthew R · CIK 0001638364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

F1 · ownership.direct: Held jointly with spouse.

Read SEC document
November 30, 2021 Filed Dec 1, 2021 00:42 UTC
Pascoe Richard WDirector · Executive Chairman
PurchaseCommon Stock 1,500 $7.88 $11,822.10
Disclosure

SEC source: 0001437749-21-027582 · rdgdoc.xml · nonDerivative · entry 1

Pascoe Richard W · CIK 0001343266 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,285

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.